Sanford C. Bernstein Reiterates €98.00 Price Target for Fresenius Medical Care AG & Co. KGaA (FME)

Fresenius Medical Care AG & Co. KGaA (ETR:FME) received a €98.00 ($113.95) price target from research analysts at Sanford C. Bernstein in a research report issued on Friday. The firm presently has a “buy” rating on the stock. Sanford C. Bernstein’s price target points to a potential upside of 57.46% from the stock’s current price.

Other equities analysts have also recently issued research reports about the stock. Goldman Sachs Group set a €98.00 ($113.95) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Monday, October 1st. UBS Group set a €86.00 ($100.00) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a report on Wednesday, October 17th. JPMorgan Chase & Co. set a €84.20 ($97.91) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research report on Friday. Commerzbank set a €79.00 ($91.86) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research report on Friday. Finally, Berenberg Bank set a €87.80 ($102.09) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research report on Friday. Nine investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Fresenius Medical Care AG & Co. KGaA has an average rating of “Buy” and an average target price of €87.36 ($101.59).

Fresenius Medical Care AG & Co. KGaA stock traded down €5.76 ($6.70) during trading hours on Friday, hitting €62.24 ($72.37). 2,805,378 shares of the company traded hands, compared to its average volume of 704,197. Fresenius Medical Care AG & Co. KGaA has a 1-year low of €75.53 ($87.83) and a 1-year high of €93.82 ($109.09).



Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Featured Article: Derivative

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply